Overactive urinary bladder: Targeting sensory pathways

Drug Discovery Today: Therapeutic Strategies

Volumn 2, Issue 1, 2005, Pages 15-23

  Lecci, Alessandro ^a   Maggi, Carlo Alberto ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ACETYLSALICYLIC ACID; ANANDAMIDE; ANTIESTROGEN; ANTISENSE OLIGONUCLEOTIDE; BOTULINUM TOXIN A; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CAPSAICIN; CAPSAZEPINE; CENTCHROMAN; CYCLOOXYGENASE 2 INHIBITOR; DARIFENACIN; DRONABINOL; ENDOTHELIN A RECEPTOR ANTAGONIST; ESTROGEN RECEPTOR ALPHA; FLURBIPROFEN; FULVESTRANT; HYBRID PROTEIN; ICATIBANT; IMATINIB; INDOMETACIN; ION CHANNEL; KETOPROFEN; KW 7158; M 274773; M274773; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR ANTAGONIST; N (4 BENZOYLPHENYL) 3,3,3 TRIFLUORO 2 HYDROXY 2 METHYLPROPIONAMIDE; NEPADUTANT; NERVE GROWTH FACTOR RECEPTOR; NOCICEPTIN; NS 8; OPIATE AGONIST; OXYBUTYNIN; PALMIDROL; POTASSIUM CHANNEL STIMULATING AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN INHIBITOR; PROTEIN P75; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE INHIBITOR; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RESINIFERATOXIN; RETIGABINE; SAREDUTANT; SDZ 249665; SODIUM CHANNEL BLOCKING AGENT; SOLIFENACIN; TACHYKININ RECEPTOR ANTAGONIST; TOLTERODINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TROSPIUM CHLORIDE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; ZD 0947;

ARTICLE; AUTONOMIC DYSREFLEXIA; AUTONOMIC NEUROPATHY; BLEEDING; BURNING SENSATION; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DRUG TARGETING; ENTEROPATHY; GENITAL SYSTEM DISEASE; HUMAN; METABOLIC DISORDER; MICTURITION DISORDER; NEPHROTOXICITY; NEUROENDOCRINE DISEASE; NEUROGENIC BLADDER; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; OVERACTIVE BLADDER; PAIN; PERIPHERAL NERVOUS SYSTEM; RECEPTOR BINDING; SENSORY NERVE; SEXUAL DYSFUNCTION; XEROSTOMIA;

EID: 21644461755     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2005.05.007     Document Type: Review

References (48)

1. J.G. Ouslander Management of overactive bladder N. Engl. J. Med. 350 2004 786-799
2. C.J. Fowler Bladder afferents and their role in the overactive bladder Urology 59 Suppl. 5A 2002 37-42
3. D. Ost et al. Topography of the vanilloid receptor in the human bladder: more than just nerve fibers J. Urol. 168 2002 293-297
4. L.A. Birder Role of the urothelium in bladder function Scand. J. Urol. Nephrol. Suppl. 215 2004 48-53
5. C.H. Fry et al. Control of bladder function by peripheral nerves; avenues for novel drug targets Urology 63 Suppl. 3A 2004 24-31
6. Y. Kubota et al. Investigation of the effect of the c-kit inhibitor Glivec on isolated guinea-pig detrusor preparations Auton. Neurosci. 115 2004 64-73
7. C.M. Brady et al. P2X3-immunoreactive nerve fibers in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin Eur. Urol. 46 2004 247-253
8. K. Kobayashi et al. Differential expression patterns of mRNA for P2X receptor subunits in neurochemically characterized dorsal root ganglion neurons in the rat J. Comp. Neurol. 481 2005 377-390
9. S.J. Schefchyk The effect of lumbosacral deafferentation on pontine micturition centre-evoked voiding in the decerebrate cat Neurosci. Lett. 99 1989 175-180
10. L.A. Birder et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1 Nat. Neurosci. 5 2002 856-860
11. P. Dinis et al. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis J. Neurosci. 24 2004 11253-11263
12. A. Lecci et al. Nociceptin and the micturition reflex Peptides 21 2000 1007-1021
13. M. Lazzeri et al. Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor hyperactivity in humans: A pilot study J. Urol. 166 2001 2237-2240
14. C.M. Brady et al. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis Mult. Scler. 10 2004 425-433
15. A.G. Hohmann M. Herkenham Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study Neuroscience 90 1999 923-931
16. W.P. Farquhar-Smith et al. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors Pain 97 2002 11-21
17. V.K. Shea et al. Sensory fibers of the pelvic nerve innervating the rat's urinary bladder J. Neurophysiol. 84 2000 1924-1933
18. H.L. Bennett et al. Estrogen receptor expression in lumbosacral dorsal root ganglion cells innervating the female rat urinary bladder Auton. Neurosci. 105 2003 90-100
19. K.E. Andersson A.J. Wein Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence Pharmacol. Rev. 56 2004 581-631
20. D.E. Bjorling et al. Neurogenic inflammation of the bladder A. Atala D. Slade eds. In Bladder Disease: Research Concepts and Clinical Applications 2003 Kluver Academic/Plenum Publishers pp 551-583
21. S.R. Goldstein N. Nanavati Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study Am. J. Obstet. Gynecol. 187 2002 521-527
22. L. Candenas et al. Tachykinins and tachykinin receptors: Effects in the genitourinary tract Life Sci. 76 2005 835-862
23. A. Sculptoreanu et al. KW-7158
24. D.A. Cockayne et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice Nature 407 2000 1011-1015
25. Cockayne, D.A. (2005) P2X receptors and ATP regulation of urinary bladder function. In Urothelial Cell Physiology in Normal and Disease States, IUPS 2005 Satellite Symposia
26. B.F. King et al. Investigation of the effects of P2 purinoceptor ligands on the micturition reflex in female urethane-anaesthetized rats Br. J. Pharmacol. 142 2004 519-530
27. T. Moriyama et al. Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor1-mediated thermal hypersensitivity J. Neurosci. 23 2003 6058-6062
28. B. Chopra et al. Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium J. Physiol. 562 2005 859-871
29. S.I. Jaggar et al. The modulatory effects of bradykinin B1 and B2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia Pain 75 1998 169-176
30. N. Dmitrieva et al. The role of nerve growth factor in a model of visceral inflammation Neuroscience 78 1997 449-459
31. L.Y. Qiao M.A. Vizzard Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways J. Comp. Neurol. 454 2002 200-211
32. S. Vaidyanathan et al. p75 nerve growth factor receptor in the vesical urothelium of patients with neuropathic bladder: An immunohistochemical study Spinal Cord 36 1998 541-547
33. Y.C. Chuang et al. The role of bladder afferent pathaways in bladder hyperactivity induced by intravesical administration of nerve growth factor J. Urol. 165 2001 975-979
34. Y.H. Zhang G.D. Nicol NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor Neurosci. Lett. 366 2004 187-192
35. J.C. Petruska L.M. Mendell The many functions of nerve growth factor: multiple actions on nociceptors Neurosci. Lett. 361 2004 168-171
36. Y. Tsukimi et al. Mechanism of action by which aspirin alleviates detrusor hyperactivity in rats J. Pharmacol. Sci. 95 2004 101-107
37. S.P.H. Alexander et al. Guide to receptors and channels Br. J. Pharmacol. 141 2004 S1-S126
38. M. Gopalakrishnan C.C. Shieh Potassium channel subtypes as molecular targets for overactive bladder and other urological disorders Expert Opin. Ther. Targets 8 2004 437-458
39. + channel J. Biol. Chem. 279 2004 36746-36752
40. J.M. Laird et al. Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice J. Neurosci. 22 2002 8352-8356
41. N. Yoshimura et al. The involvement of the tetrodotoxin-resistant sodium channel Na(v)1.8 (PN3/SNS) in a rat model of visceral pain J. Neurosci. 21 2001 8690-8696
42. S. De Wachter J.J. Wyndaele Intravesical oxybutynin: A local anesthetic effect on bladder C afferents J. Urol. 169 2003 1892-1895
43. Y. Kim et al. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways Urology 65 2005 238-242
44. C.P. Smith et al. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis Urology 64 2004 871-875
45. Y.C. Chuang et al. Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats J. Urol. 172 2004 1529-1532
46. M. Khera et al. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury Neurochem. Int. 45 2004 987-993
47. S.I. Jaggar et al. The capsaicin analogue SDZ249-665 attenuates the hyper-reflexia and referred hyperalgesia associated with inflammation of the rat urinary bladder Pain 89 2001 229-235
48. T. Ogawa et al. Differential roles of peripheral and spinal endothelin receptors in the micturition reflex in rats J. Urol. 172 2004 1533-1537